These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1291700)

  • 21. Effectiveness of cyproterone acetate in achieving castration and preventing luteinizing hormone releasing hormone analogue induced testosterone surge in patients with prostate cancer.
    Appu S; Lawrentschuk N; Grills RJ; Neerhut G
    J Urol; 2005 Jul; 174(1):140-2. PubMed ID: 15947599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual.
    García-Malpartida K; Martín-Gorgojo A; Rocha M; Gómez-Balaguer M; Hernández-Mijares A
    Fertil Steril; 2010 Aug; 94(3):1097.e13-5. PubMed ID: 20227072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacologic inhibition of the libido: therapy or repression? I. Pharmacologic aspects. Effect of sex hormones and in particular testosterone on male behavior. Effect of cyproterone acetate].
    Legros JJ
    Acta Psychiatr Belg; 1982; 82(5):505-19. PubMed ID: 6221507
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacologic inhibition of the libido: therapy or repression? II. Clinical aspects].
    Servais JF
    Acta Psychiatr Belg; 1982; 82(5):520-46. PubMed ID: 6221508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modification of fertility of the male by antiandrogens].
    Moltz L; Neumann F; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):18-32. PubMed ID: 6219927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hormonal treatment of sexual offenders.
    Bradford JM
    Bull Am Acad Psychiatry Law; 1983; 11(2):159-69. PubMed ID: 6225477
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-dose cyproterone acetate plus mini-dose diethylstilbestrol--a protocol for reversible medical castration.
    Goldenberg SL; Bruchovsky N; Gleave ME; Sullivan LD
    Urology; 1996 Jun; 47(6):882-4. PubMed ID: 8677581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Androcur (cyproterone acetate in sex offenses--follow-up of psychiatric admissions].
    Ahrens R
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):171-88. PubMed ID: 1710391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum testosterone determination in the antiandrogen therapy of sexual deviations with cyproterone acetate (preliminary report of experiences)].
    Glander HJ; Sorger D
    Psychiatr Neurol Med Psychol (Leipz); 1984 Oct; 36(10):596-603. PubMed ID: 6240067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyproterone acetate in the treatment of sexual disorders: pharmacological base and clinical experience.
    Neumann F; Kalmus J
    Exp Clin Endocrinol; 1991; 98(2):71-80. PubMed ID: 1838080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
    Tao Y; Dai Q; Zhang D
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):528-32. PubMed ID: 11360636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term side-effects following cyproterone acetate containing therapy in gynecology].
    Regidor PA; Speer K; Regidor M; Schindler EM
    Zentralbl Gynakol; 2000; 122(5):268-73. PubMed ID: 10857213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen deprivation therapy (castration therapy) and pedophilia: What's new.
    Silvani M; Mondaini N; Zucchi A
    Arch Ital Urol Androl; 2015 Sep; 87(3):222-6. PubMed ID: 26428645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progestogens in the treatment of male sex offenders: a review.
    Cooper AJ
    Can J Psychiatry; 1986 Feb; 31(1):73-9. PubMed ID: 2936441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment.
    Defreyne J; Nota N; Pereira C; Schreiner T; Fisher AD; den Heijer M; T'Sjoen G
    LGBT Health; 2017 Oct; 4(5):328-336. PubMed ID: 28880825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.